These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38522962)

  • 1. Stage of fibrosis is not a predictive determinant of weight loss in patients undergoing bariatric surgery.
    Brol MJ; Drebber U; Yu X; Schierwagen R; Gu W; Plamper A; Klein S; Odenthal M; Uschner FE; Praktiknjo M; Trebicka J; Rheinwalt KP
    Surg Obes Relat Dis; 2024 Aug; 20(8):759-766. PubMed ID: 38522962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Weight Loss After Bariatric Surgery Predicts an Improvement in the Non-alcoholic Fatty Liver Disease (NAFLD) Fibrosis Score.
    Yeo SC; Ong WM; Cheng KSA; Tan CH
    Obes Surg; 2019 Apr; 29(4):1295-1300. PubMed ID: 30635812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bariatric Surgery as an Efficient Treatment for Non-Alcoholic Fatty Liver Disease in a Prospective Study with 1-Year Follow-up : BariScan Study.
    Nickel F; Tapking C; Benner L; Sollors J; Billeter AT; Kenngott HG; Bokhary L; Schmid M; von Frankenberg M; Fischer L; Mueller S; Müller-Stich BP
    Obes Surg; 2018 May; 28(5):1342-1350. PubMed ID: 29119336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modified thresholds for fibrosis risk scores in nonalcoholic fatty liver disease are necessary in the obese.
    Ooi GJ; Burton PR; Doyle L; Wentworth JM; Bhathal PS; Sikaris K; Cowley MA; Roberts SK; Kemp W; O'Brien PE; Brown WA
    Obes Surg; 2017 Jan; 27(1):115-125. PubMed ID: 27220852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Use of Noninvasive Scores in Predicting NAFLD Progression After Bariatric Surgery.
    Ahmed L; Gebran S; Persaud A; Saeed K; Khan K; Saeed S; Alothman S; Passos-Fox B; DePaz H; Suman P
    Obes Surg; 2023 Dec; 33(12):4026-4033. PubMed ID: 37884692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of Non-alcoholic Fatty Liver Disease (NAFLD) Biomarkers in Response to Weight Loss 1 Year After Bariatric Surgery-a Post Hoc Analysis of the FibroTest Prospective Study.
    Codjia T; Rebibo L; François A; Lagnel C; Huet E; Bekri S; Pattou F; Régimbeau JM; Schwarz L
    Obes Surg; 2021 Aug; 31(8):3548-3556. PubMed ID: 33844174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The diagnostic accuracy of transient elastography for the diagnosis of liver fibrosis in bariatric surgery candidates with suspected NAFLD.
    Naveau S; Lamouri K; Pourcher G; Njiké-Nakseu M; Ferretti S; Courie R; Tranchart H; Ghinoiu M; Balian A; Prévot S; Perlemuter G; Dagher I
    Obes Surg; 2014 Oct; 24(10):1693-701. PubMed ID: 24841950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of Liver Stiffness with 2D-Shear Wave Elastography (2D-SWE) in Bariatric Surgery Candidates Reveals Acceptable Diagnostic Yield Compared to Liver Biopsy.
    Jamialahmadi T; Nematy M; Jangjoo A; Goshayeshi L; Rezvani R; Ghaffarzadegan K; Nooghabi MJ; Shalchian P; Zangui M; Javid Z; Doaei S; Rajabzadeh F
    Obes Surg; 2019 Aug; 29(8):2585-2592. PubMed ID: 31077025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of a preoperative low-calorie diet on liver histology in patients with fatty liver disease undergoing bariatric surgery.
    Wolf RM; Oshima K; Canner JK; Steele KE
    Surg Obes Relat Dis; 2019 Oct; 15(10):1766-1772. PubMed ID: 31558407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of bariatric surgery in patients with advanced fibrosis.
    Singh T; Kochhar GS; Goh GB; Schauer P; Brethauer S; Kroh M; Aminian A; Lopez R; Dasarathy S; McCullough AJ
    Int J Obes (Lond); 2017 Mar; 41(3):443-449. PubMed ID: 27881858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reliability of Non-invasive Liver Fibrosis Assessment Tools Versus Biopsy in Pre- and Post-bariatric Surgery Patients with Non-alcoholic Fatty Liver Disease.
    Schwenger KJP; Alali M; Ghorbani Y; Fischer SE; Jackson TD; Okrainec A; Allard JP
    Obes Surg; 2023 Jan; 33(1):247-255. PubMed ID: 36464738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bariatric Surgery Provides Long-term Resolution of Nonalcoholic Steatohepatitis and Regression of Fibrosis.
    Lassailly G; Caiazzo R; Ntandja-Wandji LC; Gnemmi V; Baud G; Verkindt H; Ningarhari M; Louvet A; Leteurtre E; Raverdy V; Dharancy S; Pattou F; Mathurin P
    Gastroenterology; 2020 Oct; 159(4):1290-1301.e5. PubMed ID: 32553765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistence of severe liver fibrosis despite substantial weight loss with bariatric surgery.
    Pais R; Aron-Wisnewsky J; Bedossa P; Ponnaiah M; Oppert JM; Siksik JM; Genser L; Charlotte F; Thabut D; Clement K; Ratziu V
    Hepatology; 2022 Aug; 76(2):456-468. PubMed ID: 35076966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of bariatric surgery on fatty liver disease in obese patients: A prospective one year follow-up study.
    Toman D; Vavra P; Jelinek P; Ostruszka P; Ihnat P; Foltys A; Pelikan A; Roman J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2022 May; 166(2):195-203. PubMed ID: 33885048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Features of nonalcoholic steatohepatitis in severely obese children and adolescents undergoing sleeve gastrectomy.
    Alqahtani A; Elahmedi M; Alswat K; Arafah M; Fagih M; Lee J
    Surg Obes Relat Dis; 2017 Sep; 13(9):1599-1609. PubMed ID: 28600116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of transient elastography (fibroscan) and impact of bariatric surgery on nonalcoholic fatty liver disease (NAFLD) in morbidly obese patients.
    Garg H; Aggarwal S; Shalimar ; Yadav R; Datta Gupta S; Agarwal L; Agarwal S
    Surg Obes Relat Dis; 2018 Jan; 14(1):81-91. PubMed ID: 29126863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Prevalence of NAFLD and Fibrosis in Bariatric Surgery Patients and the Reliability of Noninvasive Diagnostic Methods.
    Soresi M; Cabibi D; Giglio RV; Martorana S; Guercio G; Porcasi R; Terranova A; Lazzaro LA; Emma MR; Augello G; Cervello M; Pantuso G; Montalto G; Giannitrapani L
    Biomed Res Int; 2020; 2020():5023157. PubMed ID: 32420347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The metabolic and liver-related outcomes of bariatric surgery in adult patients with insulin-treated type 2 diabetes and nonalcoholic fatty liver disease at high risk of liver fibrosis.
    Alkharaiji M; Anyanwagu U; Crabtree T; Idris I
    Surg Obes Relat Dis; 2021 Apr; 17(4):792-798. PubMed ID: 33676874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of the Bard Scoring System in Bariatric Surgery Patients with Nonalcoholic Fatty Liver Disease.
    Nassif AT; Nagano TA; Okayama S; Nassif LS; Branco Filho A; Sampaio Neto J
    Obes Surg; 2017 Feb; 27(2):394-398. PubMed ID: 27392972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histologic improvement of NAFLD in patients with obesity after bariatric surgery based on standardized NAS (NAFLD activity score).
    von Schönfels W; Beckmann JH; Ahrens M; Hendricks A; Röcken C; Szymczak S; Hampe J; Schafmayer C
    Surg Obes Relat Dis; 2018 Oct; 14(10):1607-1616. PubMed ID: 30146425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.